Among other things, the chamber's study -- based on interviews with officials at 35 companies across the state -- calls for exempting public companies with less than US$125 million in revenue from implementing the Act's Section 404, which requires extensive internal and external auditing procedures.
The anti-corruption Sarbanes-Oxley law is stunting innovation and growth among smaller Masschusetts high-tech and biotech firms, according to a new report that recommends the feds reduce the red tape burdening companies.
"It disproportionately impacts the [technology] sector," said Paul Guzzi, president of the Greater Boston Chamber of Commerce, which commissioned the study.
See full Article.
Posts
